pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·2h ago·1 min read
save

AI health startup Ortet launches with $500M backing from former Genentech AI team

Sep 29, 2026·read at Endpoints ↗DealPositive

Ortet, a new health-technology company, announced its launch on Tuesday.

The firm was founded by three former AI scientists and engineers who previously worked at Roche's Genentech division.

Ortet disclosed that it has secured a $500 million funding commitment to develop AI tools aimed at transforming the healthcare system.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “AI health startup Ortet launches with $500M and co-founders from Genentech”

read at Endpoints ↗
92 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
GENENTECH3ROCHE3

related stories

  • 5d agoMerck sees pivotal victory for $3B eye disease prospectFierce Biotech
  • 6d agoNovo workforce down 13,000BioSpace
  • Sep 17Roche, Dualitas team up to find bispecific drugs for immune diseasesBioPharma Dive
  • Sep 17Roche signs $1B deal with Dualitas to pair up on big bispecific screening driveFierce Biotech
  • Sep 145 drugmakers chasing Merck and Moderna in the cancer vaccine raceBioSpace